Cite
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study
MLA
M. Laviolette, et al. “Longitudinal Stability of Asthma Characteristics and Biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) Study.” Respiratory Research, vol. 17, Apr. 2016. EBSCOhost, https://doi.org/10.1186/s12931-016-0360-5.
APA
M. Laviolette, Pascal Chanez, Pierre-Olivier Girodet, Steven G. Kelsen, Sumita Khatri, JM FitzGerald, Elliot S. Barnathan, Celeste Porsbjerg, Joel N. Kline, Vedrana S. Susulic, Philip E. Silkoff, Vibeke Backer, Dave Singh, Matthew J. Loza, Patrick Berger, & F. Baribaud. (2016). Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study. Respiratory Research, 17. https://doi.org/10.1186/s12931-016-0360-5
Chicago
M. Laviolette, Pascal Chanez, Pierre-Olivier Girodet, Steven G. Kelsen, Sumita Khatri, JM FitzGerald, Elliot S. Barnathan, et al. 2016. “Longitudinal Stability of Asthma Characteristics and Biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) Study.” Respiratory Research 17 (April). doi:10.1186/s12931-016-0360-5.